Ó³»­´«Ã½

Fu J, Waks AG, Pimenta E, et al. Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer. Nature communications. 2025;16(1):10704. doi:10.1038/s41467-025-66659-y

Ricci C, Midroit MJ, Caicci F, Achsel T, Domínguez-Iturza N, Bagni C. CYFIP1 governs the development of cortical axons by modulating calcium availability. Nature communications. 2025;16(1):10764. doi:10.1038/s41467-025-65801-0

Kato N, Comer E, Sakata-Kato T, et al. Author Correction: Diversity-oriented synthesis yields novel multistage antimalarial inhibitors. Nature. 2025. doi:10.1038/s41586-025-09938-4

Abu-Remaileh M, Stransky LA, Bhalerao N, et al. Targeting of HIF2-driven cachexia in kidney cancer. Nature medicine. 2025. doi:10.1038/s41591-025-04054-2

Lee DSM, Cardone KM, Zhang DY, et al. Author Correction: Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum. Nature genetics. 2025. doi:10.1038/s41588-025-02464-z

Casola C, Luria V, Vakirlis N, Zhao L. De novo genes: current status and future goals. Genome biology and evolution. 2025. doi:10.1093/gbe/evaf230

Said SA, Patel SM, Melloni GEM, et al. A polygenic risk score for peripheral artery disease and major adverse limb events. European heart journal. 2025. doi:10.1093/eurheartj/ehaf891

de Mello SS, Schultz B, Goh B, et al. Loss of LafB activity reverses daptomycin resistance in . mBio. 2025:e0071525. doi:10.1128/mbio.00715-25

Webb RF, McCurry H, Girod A, et al. Evidence-based classification of genes implicated in skeletal disorders using the ClinGen curation framework. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2025. doi:10.1093/jbmr/zjaf183

White S, Liao Y, Burton EM, Asara JM, Gewurz BE. Arginine Metabolism Supports Pyrimidine Biosynthesis to Block DNA Damage and Maintain Epstein-Barr Virus Latency. bioRxiv : the preprint server for biology. 2025. doi:10.1101/2025.10.21.683727